Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk R J Kuypers

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2018
Tacrolimus Formulations and African American Kidney Transplant Recipients: When Do Details Matter?Dirk R J Kuypers
Nature Clinical Practice. Nephrology|February 5, 2009
Skin problems in chronic kidney diseaseDirk R J Kuypers
Lancet (London, England)|August 1, 2014
Alemtuzumab induction therapy in kidney transplantationDirk R J Kuypers
Drug Safety|February 5, 2005
Benefit-risk assessment of sirolimus in renal transplantationDirk R J Kuypers
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcomeDirk R J Kuypers
Clinical Pharmacology and Therapeutics|August 27, 2019
Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical OutcomeDirk R J Kuypers
Nature Reviews. Nephrology|April 18, 2012
Management of polyomavirus-associated nephropathy in renal transplant recipientsDirk R J Kuypers
Clinical Pharmacology and Therapeutics|May 29, 2025
Current Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus NephritisDirk R J Kuypers
Transplantation|May 24, 2008
Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effectDirk R J Kuypers
Transplantation|January 14, 2020
From Nonadherence to AdherenceDirk R J Kuypers
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2018
Tacrolimus Formulations and African American Kidney Transplant Recipients: When Do Details Matter?Dirk R J Kuypers
Nature Clinical Practice. Nephrology|February 5, 2009
Skin problems in chronic kidney diseaseDirk R J Kuypers
Lancet (London, England)|August 1, 2014
Alemtuzumab induction therapy in kidney transplantationDirk R J Kuypers
Drug Safety|February 5, 2005
Benefit-risk assessment of sirolimus in renal transplantationDirk R J Kuypers
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcomeDirk R J Kuypers
Clinical Pharmacology and Therapeutics|August 27, 2019
Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical OutcomeDirk R J Kuypers
Nature Reviews. Nephrology|April 18, 2012
Management of polyomavirus-associated nephropathy in renal transplant recipientsDirk R J Kuypers
Clinical Pharmacology and Therapeutics|May 29, 2025
Current Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus NephritisDirk R J Kuypers
Transplantation|May 24, 2008
Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effectDirk R J Kuypers
Transplantation|January 14, 2020
From Nonadherence to AdherenceDirk R J Kuypers
Pageof 10